Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-08-08
1993-03-23
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549267, C07D49322, A61K 31365
Patent
active
051964473
ABSTRACT:
The marine bryozoan Bugula neritina has been found to contain a novel 22-membered macrocyclic lactone which is an inhibitor of lymphocytic leukemia as measured by the US National Cancer Institute's P 388 and in vitro evaluation system. The novel lactone is herein denominated "neristatin 1" and is elucidated.
REFERENCES:
patent: 4560774 (1985-12-01), Pettit et al.
patent: 4611066 (1986-09-01), Pettit et al.
patent: 4833257 (1989-05-01), Pettit et al.
Gao Feng
Pettit George R.
Arizona Board of Regents, a body Corporate of The State of Arizo
Ivy C. Warren
Mybeck Richard R.
Owens A. A.
LandOfFree
Neristatin 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neristatin 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neristatin 1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1352034